NASDAQ:CLXT - Calyxt Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$14.78 -0.12 (-0.81 %)
(As of 05/23/2019 04:00 PM ET)
Previous Close$14.90
Today's Range$14.60 - $15.11
52-Week Range$8.83 - $22.32
Volume31,636 shs
Average Volume59,703 shs
Market Capitalization$483.34 million
P/E RatioN/A
Dividend YieldN/A
Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. operates as a subsidiary of Cellectis S.A.

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural chemicals
SectorConsumer Staples
Current SymbolNASDAQ:CLXT



Sales & Book Value

Annual Sales$240,000.00
Book Value$2.68 per share


Net Income$-27,900,000.00
Net Margins-8,089.53%


Market Cap$483.34 million
Next Earnings Date8/7/2019 (Estimated)
OptionableNot Optionable

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) released its quarterly earnings data on Tuesday, May, 7th. The company reported ($0.23) EPS for the quarter, beating analysts' consensus estimates of ($0.28) by $0.05. The firm had revenue of $0.16 million for the quarter, compared to analysts' expectations of $1.80 million. Calyxt had a negative return on equity of 31.89% and a negative net margin of 8,089.53%. View Calyxt's Earnings History.

When is Calyxt's next earnings date?

Calyxt is scheduled to release their next quarterly earnings announcement on Wednesday, August 7th 2019. View Earnings Estimates for Calyxt.

What price target have analysts set for CLXT?

4 analysts have issued 1 year target prices for Calyxt's stock. Their predictions range from $16.00 to $35.00. On average, they expect Calyxt's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 62.4% from the stock's current price. View Analyst Price Targets for Calyxt.

What is the consensus analysts' recommendation for Calyxt?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Calyxt.

What are Wall Street analysts saying about Calyxt stock?

Here are some recent quotes from research analysts about Calyxt stock:
  • 1. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (5/14/2019)
  • 2. National Securities analysts commented, " First Quarter In Line. Modest initial commercial revenues and a net loss of $0.23 per share fell in line with our estimates. We are maintaining our full year outlook for 2019 and expect meaningful acceleration of revenue growth in 2020 and beyond.
     Grower Demand Strong. Contracted Calyno acreage more than tripled from 2018 to 2019, from 17,000 acres to 55,000 acres. We believe Calyno represents a meaningful source of value for soybean growers who struggle to turn a profit amid low commodity prices and the ongoing tariff and trade struggle with China. Given Calyno’s premium pricing and domestic demand, we believe grower demand will be strong for years to come.
     Commercial Revenues Realized, Customer Relationships Progressing. Initial sales for both oil and meal occurred this year, and we expect the balance of the 2018 harvest will be sold out in coming months. In addition, a distribution agreement with a major food service distributor is now in place, which we expect will accelerate sales of Calyno oil in coming years as supply builds.
     An Overlooked Investment. In our view, Calyxt represents a first mover capitalizing on a consumer driven, fundamental shift in food chain with a high degree of visibility of revenue in excess of $1 billion from its lead product alone. Last week, the market shared a similar perspective in the IPO of Beyond Meat (NASD: BYND – NR - $72.25). While there are some clear differences between the two, we believe the value proposition for both is more similar than may initially meet the eye." (5/9/2019)

Has Calyxt been receiving favorable news coverage?

News stories about CLXT stock have trended somewhat positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Calyxt earned a coverage optimism score of 1.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near term.

Who are some of Calyxt's key competitors?

What other stocks do shareholders of Calyxt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calyxt investors own include Cellectis (CLLS), Cypress Semiconductor (CY), Molecular Templates (MTEM), Netflix (NFLX), Advanced Micro Devices (AMD), Secureworks (SCWX), Eaton (ETN), Square (SQ), Arena Pharmaceuticals (ARNA) and Array Biopharma (ARRY).

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:
  • Mr. James A. Blome, Chief Exec. Officer (Age 56)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)
  • Mr. Manoj Sahoo, Chief Commercial Officer (Age 44)
  • Mr. William F. Koschak, Chief Financial Officer (Age 50)
  • Mr. Eric Dutang, Principal Accounting Officer (Age 45)

When did Calyxt IPO?

(CLXT) raised $101 million in an initial public offering on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Who are Calyxt's major shareholders?

Calyxt's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (14.99%), BlackRock Inc. (1.42%), Nikko Asset Management Americas Inc. (1.07%), Sumitomo Mitsui Trust Holdings Inc. (1.04%), Northern Trust Corp (0.27%) and California Public Employees Retirement System (0.27%). Company insiders that own Calyxt stock include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, James Blome, Manoj Sahoo, Michel Arbadji, Philippe Dumont, SA Cellectis and Yves J Ribeill. View Institutional Ownership Trends for Calyxt.

Which major investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Wells Fargo & Company MN, Morgan Stanley, RMB Capital Management LLC, Essex Investment Management Co. LLC and HighTower Advisors LLC. Company insiders that have sold Calyxt company stock in the last year include Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, James Blome, Manoj Sahoo, Michel Arbadji, Philippe Dumont and Yves J Ribeill. View Insider Buying and Selling for Calyxt.

Which major investors are buying Calyxt stock?

CLXT stock was acquired by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Sumitomo Mitsui Trust Holdings Inc., BlackRock Inc., California Public Employees Retirement System, Neuberger Berman Group LLC, FMR LLC, Granite Investment Partners LLC and Gilder Gagnon Howe & Co. LLC. Company insiders that have bought Calyxt stock in the last two years include Philippe Dumont and SA Cellectis. View Insider Buying and Selling for Calyxt.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $14.78.

How big of a company is Calyxt?

Calyxt has a market capitalization of $483.34 million and generates $240,000.00 in revenue each year. The company earns $-27,900,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis. Calyxt employs 50 workers across the globe.

What is Calyxt's official website?

The official website for Calyxt is

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]

MarketBeat Community Rating for Calyxt (NASDAQ CLXT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  174 (Vote Outperform)
Underperform Votes:  181 (Vote Underperform)
Total Votes:  355
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/23/2019 by Staff

Featured Article: What is a short straddle?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel